Literature DB >> 33493547

Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.

Catherine F Moore1, Catherine M Davis2, Eric L Harvey3, Michael A Taffe3, Elise M Weerts2.   

Abstract

Advances in drug vapor exposure systems have enabled evaluation of Δ-9-tetrahydrocannabinol (THC) vapor effects in laboratory animals. The purpose of this study was to 1) establish a range of parameters of THC vapor exposure in rats sufficient to produce a behavioral dose-effect curve in a battery of tasks sensitive to THC; and 2) to investigate sex differences in the effects of THC vapor exposure and THC injection (intraperitoneal, IP) on these behaviors in two strains of outbred rats. Male and female Sprague Dawley and Wistar rats (N = 22, 5-6/sex per group) received THC via passive vapor exposure (200 mg/mL; 5 conditions) and IP injection (1-20 mg/kg) in a within subject design. The effects of vaped and injected THC on appetite was determined using progressive ratio responding for food pellets. THC effects on nociception, measured using the tail withdrawal assay, and body temperature were also assessed during a 5-h test period for evaluation of time course of effects. Plasma THC concentrations were assessed after THC vapor and 10 mg/kg IP THC. THC vapor produced exposure-related increases and decreases in motivation to obtain food under the progressive ratio schedule. IP THC (3-20 mg/kg) reduced breakpoints. Vaped and injected THC produced exposure and dose-dependent antinociception and hypothermia. Sex and strain differences in THC effects were also observed. Plasma THC concentrations were higher after 10 mg/kg IP THC (152 ng/mL) compared to the highest vapor exposure condition tested (38 ng/mL), but magnitude of behavioral effects were comparable. THC vapor exposure produced reliable, dose orderly effects on food-maintained behavior, nociception, and body temperature that are comparable to effects of IP THC, although there were differences in the time course of behavioral outcomes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appetite; Cannabinoids; Hypothermia; Nociception; THC; Vapor exposure

Mesh:

Substances:

Year:  2021        PMID: 33493547      PMCID: PMC7878393          DOI: 10.1016/j.pbb.2021.173116

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  45 in total

1.  Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats.

Authors:  Jacques D Nguyen; K M Creehan; Yanabel Grant; Sophia A Vandewater; Tony M Kerr; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2020-07-16       Impact factor: 4.492

2.  Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

3.  Modes of marijuana use - smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States.

Authors:  Gillian L Schauer; Rashid Njai; Althea M Grant-Lenzy
Journal:  Drug Alcohol Depend       Date:  2020-02-06       Impact factor: 4.492

4.  Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.

Authors:  Cristina Irimia; Ilham Y Polis; David Stouffer; Loren H Parsons
Journal:  Psychopharmacology (Berl)       Date:  2015-04-30       Impact factor: 4.530

5.  Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.

Authors:  J Hirvonen; R S Goodwin; C-T Li; G E Terry; S S Zoghbi; C Morse; V W Pike; N D Volkow; M A Huestis; R B Innis
Journal:  Mol Psychiatry       Date:  2011-07-12       Impact factor: 15.992

6.  Sex differences in antinociceptive and motoric effects of cannabinoids.

Authors:  A H Tseng; R M Craft
Journal:  Eur J Pharmacol       Date:  2001-10-26       Impact factor: 4.432

7.  Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.

Authors:  Michael A Taffe; Kevin M Creehan; Sophia A Vandewater
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

8.  Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats.

Authors:  Jacques D Nguyen; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

Review 9.  E-Cigarettes: A Review of New Trends in Cannabis Use.

Authors:  Christian Giroud; Mariangela de Cesare; Aurélie Berthet; Vincent Varlet; Nicolas Concha-Lozano; Bernard Favrat
Journal:  Int J Environ Res Public Health       Date:  2015-08-21       Impact factor: 3.390

10.  Substances used in electronic vapor products among adults in the United States, 2017.

Authors:  Katrina F Trivers; Andrea S Gentzke; Elyse Phillips; Michael Tynan; Kristy L Marynak; Gillian L Schauer
Journal:  Addict Behav Rep       Date:  2019-10-17
View more
  5 in total

1.  Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.

Authors:  C M Ruiz; A Torrens; V Lallai; E Castillo; L Manca; M X Martinez; D N Justeson; C D Fowler; D Piomelli; S V Mahler
Journal:  Psychopharmacology (Berl)       Date:  2021-09-08       Impact factor: 4.530

2.  Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.

Authors:  Catherine F Moore; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2021-10-15       Impact factor: 4.415

3.  Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.

Authors:  Grant C Glatfelter; John S Partilla; Michael H Baumann
Journal:  Neuropsychopharmacology       Date:  2021-11-20       Impact factor: 8.294

4.  Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules.

Authors:  Ayat Zagzoog; Ashley Cabecinha; Hanan Abramovici; Robert B Laprairie
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

5.  Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats.

Authors:  Jenny L Wiley; Shanequa I Taylor; Julie A Marusich
Journal:  Drug Alcohol Depend       Date:  2021-06-23       Impact factor: 4.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.